Kestra Advisory Services’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.84M | Sell |
22,233
-69
| -0.3% | -$5.72K | 0.01% | 1122 |
|
|
2025
Q1 | $1.81M | Sell |
22,302
-3,539
| -14% | -$287K | 0.01% | 1033 |
|
|
2024
Q4 | $2.33M | Sell |
25,841
-8,209
| -24% | -$739K | 0.01% | 920 |
|
|
2024
Q3 | $3.36M | Sell |
34,050
-4,238
| -11% | -$419K | 0.02% | 723 |
|
|
2024
Q2 | $3.55M | Buy |
38,288
+8,819
| +30% | +$818K | 0.02% | 710 |
|
|
2024
Q1 | $2.8M | Buy |
29,469
+9,114
| +45% | +$865K | 0.02% | 736 |
|
|
2023
Q4 | $1.82M | Sell |
20,355
-3,003
| -13% | -$268K | 0.01% | 835 |
|
|
2023
Q3 | $1.71M | Buy |
23,358
+1,265
| +6% | +$92.4K | 0.02% | 747 |
|
|
2023
Q2 | $1.84M | Buy |
22,093
+202
| +0.9% | +$16.8K | 0.02% | 704 |
|
|
2023
Q1 | $1.67M | Sell |
21,891
-693
| -3% | -$52.8K | 0.02% | 720 |
|
|
2022
Q4 | $1.87M | Sell |
22,584
-581
| -3% | -$48.2K | 0.02% | 776 |
|
|
2022
Q3 | $1.84M | Sell |
23,165
-7,768
| -25% | -$616K | 0.02% | 701 |
|
|
2022
Q2 | $2.3M | Sell |
30,933
-706
| -2% | -$52.4K | 0.02% | 624 |
|
|
2022
Q1 | $2.84M | Buy |
31,639
+1,499
| +5% | +$135K | 0.03% | 552 |
|
|
2021
Q4 | $3.37M | Sell |
30,140
-3,136
| -9% | -$351K | 0.03% | 498 |
|
|
2021
Q3 | $4.18M | Sell |
33,276
-6,024
| -15% | -$757K | 0.04% | 451 |
|
|
2021
Q2 | $5.32M | Sell |
39,300
-1,934
| -5% | -$262K | 0.06% | 344 |
|
|
2021
Q1 | $5.59M | Buy |
41,234
+13,801
| +50% | +$1.87M | 0.07% | 311 |
|
|
2020
Q4 | $3.95M | Buy |
27,433
+7,704
| +39% | +$1.11M | 0.05% | 394 |
|
|
2020
Q3 | $2.2M | Buy |
+19,729
| New | +$2.2M | 0.04% | 408 |
|